SARS-CoV-2 Antibodies Seroconversion in Healthcare Workers at a Tertiary Cancer Center

Mahmoud Al-Masri; Maysa Al-Hussaini; Mohamad K. Abou Chaar; Fadi Alwaneh; Hani Al-Najjar; Khawlah Ammar

doi:10.58877/japaj.v1i2.17

Authors

Mahmoud Al-Masri Department of Surgery, King Hussein Cancer Center, Amman, Jordan
Maysa Al-Hussaini Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan
Mohamad K. Abou Chaar Mayo Clinic
Fadi Alwaneh King Hussein Cancer Center, Amman, Jordan
Hani Al-Najjar Department of Surgery, King Hussein Cancer Center, Amman, Jordan
Khawlah Ammar Survey Unit and Research Office, King Hussein Cancer Center, Amman, Jordan

DOI:

https://doi.org/10.58877/japaj.v1i2.17

Keywords:

COVID-19, seroconversion, pandemic, healthcare workers, IgG, IgM, immunoglobulins

Abstract

Background:

Implementation of strict measures to ensure the safety of cancer patients during the coronavirus disease (COVID-19) pandemic includes modification of treatment plans, strict physical distancing measures between healthcare workers (HCWs) and patients alike, and early detection of suspected cases. Serological testing can identify immunological responses, i.e., seroconversion, in HCWs presenting with subclinical symptoms. The detection of immunoglobulin (Ig) M specific antibodies demonstrates active disease, while (Ig) G specific antibodies indicate previous exposure to SARS-CoV-2.

Methods:

Among HCWs in a tertiary cancer center in Jordan, a cross-sectional study was conducted to detect those who had positive serology albeit previous negative diagnosis with COVID-19. We sent an invitation e-mail, and those who met the criteria were invited to a privately designated room to sign an informed consent form and obtain a blood sample for analysis. Results and demographic data were analyzed using SAS version 9.4.

Findings:

We recruited 583 participants between December 2020 and January 2021, with an equal distribution between genders and a mean age of 34.04 years (±9.29). The majority of participants were from the nursing department (n=390, 66.89%). A history of an upper respiratory tract infection was reported by 144 individuals (24.7%) with varying symptoms. Positive exposure was reported in 441 participants (75.6%). IgG seroconversion was detected in 41 participants (7%), while IgM seroconversion was only detected in three (0.5%).

Interpretation:

There was no correlation between positive IgG seroconversion and history of upper respiratory tract infection, exposure to infected patients, or profession. Therefore, subclinical COVID-19 is hard to detect, facilitating transmission of infection. Alongside polymerase chain reaction testing, strict physical distancing, and prompt vaccination among HCWs to mitigate disease spread, frequent serological surveillance can offer a way to understand the number of infections at different times and locations within different populations.

References

Tang B, Bragazzi N, Li Q, Tang S, Xiao Y, Wu J. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious Disease Modelling. 2020;5:248-255.

Gallagher T, Buchmeier M. Coronavirus Spike Proteins in Viral Entry and Pathogenesis. Virology. 2001;279(2):371-374.

Update: ‘A Bit Chaotic.’ Christening of New Coronavirus and Its Disease Name Create Confusion [Internet]. https://www.sciencemag.org/news/2020/02/bit-chaotic-christening-new-coronavirus-and-its-diseasename-create-confusion. 2020 [cited 10 May 2020]. Available from: https://www.sciencemag.org/news/2020/02/bit-chaotic-christening-new-coronavirus-and-its-diseasename-create-confusion

Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Internet]. 2020 [cited March 2020]. Available from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

Ministry of Health, the official website of the Jordanian Ministry of Health | Coronavirus disease [Internet]. Corona.moh.gov.jo. 2020 [cited March 2021]. Available from: https://corona.moh.gov.jo/en

WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March 2020 [Internet]. World Health Organization. 2020 [cited March 2020]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020

Burbelo P, Riedo F, Morishima C, Rawlings S, Smith D, Das S et al. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. The Journal of Infectious Diseases. 2020;222(2):206-213.

Sethuraman N, Jeremiah S, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 2020;323(22):2249.

Corman V, Albarrak A, Omrani A, Albarrak M, Farah M, Almasri M et al. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection. Clinical Infectious Diseases. 2016;:civ951.

Li G, Chen X, Xu A. Profile of Specific Antibodies to the SARS-Associated Coronavirus. New England Journal of Medicine. 2003;349(5):508-509.

Hsueh P, Huang L, Chen P, Kao C, Yang P. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clinical Microbiology and Infection. 2004;10(12):1062-1066.

Park W, Perera R, Choe P, Lau E, Choi S, Chun J et al. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerging Infectious Diseases. 2015;21(12):2186-2189.

Drosten C, Meyer B, Müller M, Corman V, Al-Masri M, Hossain R et al. Transmission of MERS-Coronavirus in Household Contacts. New England Journal of Medicine. 2014;371(9):828-835.

To K, Tsang O, Leung W, Tam A, Wu T, Lung D et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. 2020;20(5):565-574.

Khan S, Nakajima R, Jain A, de Assis R, Jasinskas A, Obiero J et al. Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray. bioRxiv.

Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan Y et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020;7(1).

Lippi G, Salvagno G, Pegoraro M, Militello V, Caloi C, Peretti A et al. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(7):1156-1159.

Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clinical Infectious Diseases. 2020;71(15):778-785.

Song J, Yun J, Noh J, Cheong H, Kim W. Covid-19 in South Korea — Challenges of Subclinical Manifestations. New England Journal of Medicine. 2020;382(19):1858-1859.

Mansour M, Leven E, Muellers K, Stone K, Mendu D, Wajnberg A. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City. Journal of General Internal Medicine. 2020;35(8):2485-2486.

Patel M, Thornburg N, Stubblefield W, Talbot H, Coughlin M, Feldstein L et al. Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee. JAMA. 2020;324(17):1781.

Oran D, Topol E. Prevalence of Asymptomatic SARS-CoV-2 Infection. Annals of Internal Medicine. 2020;173(5):362-367.

Rivett L, Sridhar S, Sparkes D, Routledge M, Jones N, Forrest S et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife. 2020;9.

Maltezou H, Theodoridou K, Poland G. Influenza immunization and COVID-19. Vaccine. 2020;38(39):6078-6079.

Bates TA, Weinstein JB, Farley S, Leier HC, Messer WB, Tafesse FG. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2. Cell Rep. 2021 Feb 16;34(7):108737. doi: 10.1016/j.celrep.2021.108737. Epub 2021 Jan 26. PMID: 33545052; PMCID: PMC7835103.

Piec I, English E, Thomas MA, Dervisevic S, Fraser WD, et al. (2021) Performance of SARS-CoV-2 serology tests: Are they good enough?. PLOS ONE 16(2): e0245914. https://doi.org/10.1371/journal.pone.0245914

Boffetta P, Violante F, Durando P, De Palma G, Pira E, Vimercati L, Cristaudo A, Icardi G, Sala E, Coggiola M, Tafuri S, Gattini V, Apostoli P, Spatari G; Working Group on SARS-CoV-2 Infection in Italian Healthcare Workers. Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study. Sci Rep. 2021 Mar 11;11(1):5788. doi: 10.1038/s41598-021-85215-4. PMID: 33707646; PMCID: PMC7970984.

Liu Y, Yang S, Hung M, Tong W, Liu Y. Protecting healthcare workers amid the COVID-19 crisis: A safety protocol in Wuhan. Frontiers in Public Health. 2020;8.